Trials / Completed
CompletedNCT00938483
Tolerability and Safety of An Infant Formula
A Multicenter, Single-blind, Randomized, Phase II Study of the Tolerability and Safety of NPS-202 in Infants With Clinically Diagnosed Cow's Milk Allergy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Perrigo Nutritionals · Industry
- Sex
- All
- Age
- 1 Day – 12 Weeks
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate an extensively hydrolyzed formula in infants with cow's milk allergy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Nutramigen Lipil (Infant formula) |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-09-01
- Completion
- 2009-01-01
- First posted
- 2009-07-14
- Last updated
- 2009-07-15
Source: ClinicalTrials.gov record NCT00938483. Inclusion in this directory is not an endorsement.